Analyst: Increasing inflation will have multimillion-dollar impact on Novo Nordisk
Increasing cost pressure will slice 10 percent off Novo Nordisk’s profit in 2023, says analyst institution Intron Health.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen
Novo Nordisk will take a blow from rising energy costs and an increasing cost pressure due to inflation, according to an analysis from UK-based global healthcare equity research firm Intron heath, which Danish business daily Børsen has seen.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.